News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
23,596 Results
Type
Article (1038)
Company Profile (4)
Press Release (22554)
Section
Business (4517)
Career Advice (3)
Deals (739)
Drug Delivery (1)
Drug Development (6199)
Employer Resources (2)
FDA (1047)
Job Trends (567)
News (12132)
Policy (1124)
Tag
2027 Genetown Elite (1)
Academia (78)
Accelerated approval (1)
Allergies (10)
Alliances (1359)
ALS (16)
Alzheimer's disease (278)
Antibody-drug conjugate (ADC) (14)
Approvals (1090)
Artificial intelligence (13)
Autoimmune disease (11)
Automation (1)
Bankruptcy (2)
Best Places to Work (561)
Biosimilars (2)
Biotechnology (2)
Bladder cancer (1)
Brain cancer (3)
Breast cancer (29)
Cancer (232)
Cardiovascular disease (23)
Career advice (3)
CAR-T (37)
Cell therapy (53)
Clinical research (5451)
Collaboration (52)
Compensation (46)
Complete response letters (1)
COVID-19 (173)
C-suite (9)
Cystic fibrosis (5)
Data (566)
Depression (16)
Diabetes (27)
Diagnostics (451)
Digital health (2)
Diversity (1)
Drug discovery (5)
Duchenne muscular dystrophy (7)
Earnings (2386)
Employer resources (2)
Events (3610)
Executive appointments (18)
FDA (1217)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (3)
Funding (29)
Gene editing (4)
Generative AI (1)
Gene therapy (17)
GLP-1 (35)
Government (178)
Guidances (16)
Healthcare (555)
HIV (11)
Huntington's disease (1)
IgA nephropathy (13)
Immunology and inflammation (14)
Immuno-oncology (1)
Indications (7)
Infectious disease (179)
Inflammatory bowel disease (9)
Influenza (2)
Intellectual property (5)
IPO (351)
Job creations (42)
Job search strategy (3)
JPM (2)
Labor market (1)
Layoffs (9)
Legal (81)
Liver cancer (2)
Longevity (2)
Lung cancer (27)
Lymphoma (23)
Machine learning (3)
Management (1)
Manufacturing (22)
MASH (4)
Medical device (197)
Medtech (199)
Mergers & acquisitions (427)
Metabolic disorders (46)
Multiple sclerosis (8)
Neurodegenerative disease (48)
Neuropsychiatric disorders (7)
Neuroscience (409)
Neurotech (1)
NextGen: Class of 2026 (160)
Non-profit (84)
Obesity (15)
Opinion (6)
Ovarian cancer (3)
Pain (3)
Pancreatic cancer (7)
Parkinson's disease (51)
Patents (7)
Patient recruitment (23)
People (778)
Pharmaceutical (2)
Phase 1 (2032)
Phase 2 (2301)
Phase 3 (1631)
Pipeline (305)
Policy (3)
Postmarket research (182)
Preclinical (592)
Press Release (1)
Prostate cancer (11)
Psychedelics (6)
Radiopharmaceuticals (4)
Rare diseases (45)
Real estate (123)
Recruiting (1)
Regulatory (1131)
Reports (1)
Research institute (83)
Rett syndrome (3)
RSV (1)
Schizophrenia (18)
Series A (5)
Series B (2)
Sickle cell disease (5)
Spinal muscular atrophy (7)
Sponsored (3)
Startups (51)
Supply chain (7)
Tariffs (1)
The Weekly (1)
Vaccines (22)
Venture capital (5)
Weight loss (6)
Date
Today (3)
Last 7 days (18)
Last 30 days (88)
Last 365 days (1382)
2026 (130)
2025 (1389)
2024 (1538)
2023 (1699)
2022 (2206)
2021 (2117)
2020 (2051)
2019 (1378)
2018 (1034)
2017 (1286)
2016 (1201)
2015 (1501)
2014 (876)
2013 (682)
2012 (700)
2011 (714)
2010 (644)
Location
Africa (12)
Alabama (1)
Arizona (4)
Asia (2113)
Australia (294)
California (437)
Canada (97)
China (65)
Colorado (7)
Connecticut (12)
Delaware (11)
Europe (3488)
Florida (132)
Georgia (23)
Illinois (22)
India (2)
Indiana (32)
Japan (32)
Kansas (6)
Louisiana (1)
Maryland (74)
Massachusetts (451)
Michigan (10)
Minnesota (18)
Missouri (8)
Montana (1)
Nebraska (2)
Nevada (1)
New Jersey (198)
New Mexico (1)
New York (130)
North Carolina (122)
Northern California (218)
Ohio (7)
Oregon (2)
Pennsylvania (103)
Puerto Rico (3)
South America (19)
Southern California (173)
Tennessee (5)
Texas (56)
United States (1850)
Utah (6)
Virginia (6)
Washington State (25)
Wisconsin (1)
23,596 Results for "bpl plasma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AtaiBeckley Announces Positive Topline Data from the Phase 2b Open-Label Extension Study of BPL-003, Supporting Safety and Efficacy of a Second Dose in Patients with Treatment-Resistant Depression
November 10, 2025
·
10 min read
Press Releases
atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression
October 17, 2025
·
7 min read
Press Releases
Zepto Life Technology Launches Plasma-Based FungiFlex® Mold Panel as CLIA Reference Laboratory Test
January 22, 2026
·
2 min read
Press Releases
Accord Plasma B.V. Expands Global Plasma Therapy Capabilities with Acquisition of Prothya Biosolutions
October 20, 2025
·
2 min read
Press Releases
atai Life Sciences and Beckley Psytech Report Positive Phase 2a Data Demonstrating Improved Outcomes with a Two-Dose Induction Regimen of BPL-003 in Patients with Treatment-Resistant Depression
September 23, 2025
·
12 min read
Press Releases
Labcorp® Plasma Detect™ Clinical Studies Featured in Nature Medicine and Clinical Cancer Research
November 20, 2025
·
3 min read
Press Releases
Resolve Therapeutics to Present at International Symposium on Circulating Nucleic Acids in Plasma and Serum (CNAPS)
November 18, 2025
·
2 min read
Press Releases
atai Life Sciences and Beckley Psytech Announce Positive Topline Results from the Phase 2b Study of BPL-003 in Patients with Treatment-Resistant Depression
July 1, 2025
·
15 min read
Press Releases
CervoMed Presents New Plasma Biomarker Data That Indicates Neflamapimod Broadly Improves Neuroinflammation and Neurodegeneration in Dementia with Lewy Bodies (DLB)
December 2, 2025
·
11 min read
Press Releases
Alzheon Reports Plasma Biomarker Results from Phase 3 and 2 Studies of Valiltramiprosate/ALZ-801, Validating Its First-in-Class Mechanism of Action and Underscoring Benefits in Cognition, Function, and Brain Volume Protection in Alzheimer’s Patients
February 3, 2026
·
12 min read
1 of 2,360
Next
